Sign in

CIK 0001615219

  • Non-accelerated filer
  • Smaller reporting company

Decoy Therapeutics Inc.

Sign in to watch
Ticker
DCOY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465087339
Phone
+1 346-772-0346
Business address
2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
Former names
Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 44 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-09-10 McVicar William K. Director Grant or award · Stock Option (right to buy) +3,000 3,000
2019-09-10 HANISH ARNOLD C Director Grant or award · Stock Option (right to buy) +3,000 3,000
2019-01-09 Boston Foundation, Inc. 10% owner Sale −337,000 $0.37 $124K 1,600,000
2019-01-08 Boston Foundation, Inc. 10% owner Sale −263,000 $0.40 $104K 1,937,000
2018-10-16 Longwood Fund II, L.P. 10% owner Sale −3,212,861 $0.92 $2.9M 0
2018-10-16 Westphal Christoph H 10% owner Sale −3,212,861 $0.92 $2.9M 0
2018-07-25 RANDLE STUART A Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-07-25 KOZIN MARC D Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-07-25 Stacy Michelle Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-07-25 Tung Roger D Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-07-25 HUTT PETER BARTON Director Grant or award · Stock Option (right to buy) +10,000 10,000
2018-06-14 McCabe John P. Chief Financial Officer Grant or award · Stock Option (right to buy) +179,848 179,848
2018-06-14 McVicar William K. President and CEO Grant or award · Stock Option (right to buy) +359,696 359,696
2018-01-17 McVicar William K. President and CEO Grant or award · Stock Option (right to buy) +250,000 250,000
2018-01-17 Woo Elizabeth SVP, Investor Relations Grant or award · Stock Option (right to buy) +50,000 50,000
2018-01-17 McCabe John P. Chief Financial Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2018-01-17 Wessel Thomas Chief Medical Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2017-11-08 Tung Roger D Director Grant or award · Stock Option (right to buy) +20,000 20,000
2017-07-26 PEREZ ROBERT J Director Grant or award · Stock Option (right to buy) +12,000 12,000
2017-07-26 Westphal Christoph H Director Grant or award · Stock Option (right to buy) +12,000 12,000

Page 7 of 12 · 229 trades